Yahoo Finance

Gabapentin Market Trends Report 2025-2030, with Key Competitor Analysis for Sun Pharmaceutical Industries, Ascend Laboratories, Apotex, Teva Pharmaceutical Industries, Arbor ...

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form, By Type, By Application, By Distribution Channel, By Region, And Segment Forecasts ...
Yahoo Finance

Gabapentin Market revenue is expected to increase by USD 4.1 Billion by 2032, with a 5.7% CAGR from 2023 to 2032

LOS ANGELES, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Gabapentin Market Size accounted for USD 2.4 Billion in 2022 and is projected to achieve a market size of USD 4.1 Billion by 2032 growing at a CAGR ...
Hosted on MSN

Gabapentin Under Scrutiny: 2025 Data Challenged Safety Profile

In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated. Since then, new risks related to gabapentin emerged and prescribing continued ...
FiercePharma

Teva and Pfizer Settle Generic Neurontin® Litigation

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that patent litigation with Pfizer Inc. related to generic versions of Pfizer’s Neurontin® (gabapentin) ...
MarketWatch

Teva gets final FDA OK for Gabapentin

SAN FRANCISCO (CBS.MW) -- Teva Pharmaceuticals said Friday afternoon that it has received final approval from the U.S. Food and Drug Administration for its Gabapentin capsules, an anti-convulsant ...